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A transgenic mouse was generated expressing on most (>80%) of thymocytes and
peripheral T cells a T-cell receptor isolated from a cytotoxic T-cell clone (F5). This clone
is CD8 and recognizes oo366-374 of the nucleoprotein (NP 366-374) of influenza virus
(A/NT/60/68), in the context of Class ,MHC D
b (Townsend et al., 1986). The receptor
utilizes the V]/11 and Vow4 gene segments for the ]/chain and c chain, respectively
(Palmer et al., 1989). The usage of V]/11 makes this TcR reactive to Class II IE molecules
and an endogenous ligand recently identified as a product of the endogenous mammary
tumour viruses (Mtv) 8, 9, and 11 (Dyson et al., 1991). Here we report the development
of F5 transgenic T cells and their function in mice of the appropriate MHC (C57BL/10
H-2b, IE-) or in mice expressing Class II MHC IE (e.g., CBA/Ca H-2
k and BALB/c H-2d)
and the endogenous Mtv ligands. Positive selection of CD8 T cells expressing the V/11
is seen in C57BL/10 transgenic mice (H-2b). Peripheral T cells from these mice are
capable of killing target cells in an antigen-dependent manner after a period of in vitro
culture with IL-2. In the presence of Class II MHC IE molecules and the endogenous
Mtv ligand, most of the single-positive cells carrying the transgenic T-cell receptor are
absent in the thymus. Unexpectedly, CD8 peripheral T-cells in these (H-2
k or H-2d) F5
mice are predominantly Vf111 positive and also have the capacity to kill targets in an
antigen-dependent manner. This is true even following backcrossing of the F5 TcR
transgene to H-2
d scid/scid mice, in which functional rearrangement of endogenous TcR
alpha- and beta-chain genes is impaired.
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INTRODUCTION
Development and differentiation of T cells are
complex processes taking place mainly in the
thymus. Stem cells originating in the fetal liver or
the adult bone marrow migrate into the thymus,
where they mature, become functionally com-
petent and are finally exported into the periph-
eral lymphoid compartment (Adkins et al., 1987).
The majority (>95%) of thymocytes and circulat-
ing T cells carry the c// TcR heterodimer
derived from the somatic rearrangement of the
TcR alpha and beta loci getes, whereas a small
*Corresponding author.
proportion (2-5%) carries the ,/c TcR hetero-
dimer derived from similar rearrangement of the
TcR ’
and loci (Davis and Bjorkman, 1988). The
T-cell receptor (TcR) is the structure that deter-
mines the antigenic specificity of the T cell and
the repertoire is selected for the ability of the T-
cell receptor to recognize self-MHC molecules
complexed or not with peptide. The development
of self-MHC restriction and self-tolerance is the
result of two major mechanisms: positive selec-
tion, during which potentially functional cells
able to recognize peptides presented by self-
MHC molecules are allowed to mature, and
negative selection, during which potentially
harmful or self-reactive cells are eliminated
(Blackman et al., 1990; von Boehmer, 1990; Loh,
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1991). The difference between these two similar
but contradictory processes may be based on
requirements for higher-affinity interaction
between components of the TcR/MHC/peptide
complex for negative selection than for positive
selection (Sprent et al., 1988; Schwartz, 1989). It is
generally thought that thymic epithelial cells
positively select those thymocytes that have a
TcR with affinity for self-MHC, whereas negative
selection is carried out following presentation of
self-antigens by bone marrow-derived thymic
stroma cells (Sprent et al., 1975; Bevan and Fink,
1978; Matzinger and Guerder, 1989; Speiser et al.,
1989; Mazda et al., 1991).
In mice, monoclonal antibodies specific for dif-
ferent TcR Vfl chains allow detection of percent-
ages of different V]/positive thymocytes in the
CD4/8
/ compartment in comparison with their
CD4
/ and CD8
/ single positive progeny. Thus,
mice showing deletion of peripheral T cells with
a particular Vfl chain have V]/-positive cells
within the CD4/8
/ double-positive but not in the
CD4
/ or CD8
/ single-positive thymocyte com-
partments. This approach, using Vfl-specific anti-
bodies, provided the first evidence for discrete
but measurable negative selection events
(Kappler et al., 1987, 1988; MacDonald et al.,
1988), and since then has provided evidence for
V]/-specific positive selection in certain circum-
stances (Blackman et al., 1989, 1990; Tomonari,
1992).
The use of T-cell receptor transgenic mice has
provided another extremely powerful way of
examining both positive and negative selection
because these mice carry a specific T-cell receptor
c/]/ heterodimer on most of their thymocytes
and mature T cells, thus allowing easy detection
of their fate (Kisielow et al., 1988a,b; Sha et al.,
1988a; Berg et al., 1989; Kaye et al., 1989; Pircher
et al., 1989).
These studies have demonstrated similarities
between the different systems, such as the posi-
tive selection in the presence of the appropriate
MHC haplotype (Teh et al., 1989; Ohashi et al.,
1990) and the deletion of developing thymocytes
in the presence of the cognate antigen (Berg et al.,
1989; Scott et al., 1989). They also revealed some
disparities. Thus, male mice carrying a TcR
recognizing the H-Y antigen delete thymocytes at
the immature double-positive stage (Kisielow et
al., 1988a) whereas mice transgenic for TcRs
reacting to Mls seem to delete single-positive
self-reacting cells (Pircher et al., 1989). It is not
clear at the moment to what these differences are
due. Analysis of more transgenic mice with dif-
ferent TcRs specific for a variety of antigens
should illuminate these disparities and help to
elucidate basic mechanisms.
In order to study the phenomena governing
selection mechanisms, we generated a C57BL/10
(H-2b) transgenic mouse carrying a specific T-cell
receptor c and fl cDNAs under the control of
CD2 promoter and Locus Control Region (LCR).
The majority of thymocytes and T cells in these
mice express the T-cell receptor from a cytotoxic
T-cell clone that recognizes a peptide from influ-
enza nucleoprotein in the context of H-2 Db. Here
we describe positive and negative selection
occurring in transgenic mice with appropriate
MHC haplotype or in mice expressing Mtv prod-
ucts that are recognized by the transgenic
receptor.
RESULTS
Generation of Transgenic Mice Carrying the
F5 T-Cell Receptor
In order to generate the constructs for microinjec-
tion, we inserted the cDNAs for the o and ]/
chains of the F5 cytotoxic clone is an artificial Eco
RI site at the 5’ untranslated region of a human
CD2 minigene (Robey et al., 1992) that has a
frameshift mutation in the CD2 coding region
(Fig. 1A). This CD2 minigene cassette provides
an intron, a polyadenylation signal, and the
human CD2 3’ regulatory (LCR) sequences,
which are sufficient to direct expression of trans-
genes in thymocytes and T cells of transgenic
mice in a tissue-specific, gene-copy-related and
position-independent manner (Greaves et al.,
1989).
The chimeric c and ]/genes were cointroduced
by egg microinjection in the genome of C57BL/10
mice, as described in Lang et al. (1988). Several
lines were generated that carried and expressed
the transgenes. We analyzed in detail a line that
contained a high number of copies of both the o-
and ]/-chain genes, as shown by Southern blot
analysis of tail DNA (Fig. 1B). Thus, on a Sou-
thern blot of Sad digested genomic DNA,
hybridized with a human CD2 cDNA probe, we
observed three bands of 2.3, 2.5, and 1.8 kb corre-F5 T-CELL-RECEPTOR TRANSGENIC MICE 161
sponding to the F5 c TcR-CD2, F5ffFcR-CD2, and
a common 3’ CD2 fragment, respectively (Fig.
1B).
In order to determine whether the integrated
hybrid transgenes could be transcribed into
mRNA containing F5 TcR o- and ]/-specific
sequences, Northern blot analysis was performed
on total RNA isolated from thymus of F5 TcR
transgenic mice (Fig. 1B). Hybridization of the
blots to Vc4- and V]/11-specific DNA probes
showed that both transgenes were transcribed in
the thymus of the transgenic mice giving rise to
mainly one band of approximately 3 kb rep-
resenting a hybrid TcR-CD2 transcript that is
larger than the normal mouse TcR o and fl
mRNAs due to the hybrid nature of the transcrip-
tional unit (Fig. 1A).
Surface Expression of the Transgenic T-Cell
Receptor in Thymus and Lymph Node of
Transgenic Mice
In order to follow the surface expression of the F5
T-cell receptor, fluorometric (FACS) analysis of
thymus and lymph node cells of transgenic mice
was performed. Thymocytes and lymph node
cells were stained with KT11, a monoclonaI anti-
body that is specific for T-cell receptors using the
V]/11 gene segment (Tomonari and Lovering,
1988). Over 80% of thymocytes of transgenic mice
were found to express the V]/11 chain, compared
with 1-4% of thymocytes from nontransgenic lit-
termates (Fig. 2A). Two distinct populations of
thymocytes with different densities of V//11 TcR
chain could be distinguished in the thymus of
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FIGURE 1. Southern and Northern
blot analysis of F5 transgenic mice.
(A) Schematic representation of the
fragments used for microinjection.
The solid box indicates the hCD2
cDNA and the striped box the
cDNAs for F5o or F5/ chains and
the lines indicate hCD2 5’ and 3’
flanking genomic sequences. (B)
DNA from tail biopsy (5 mg) from
F5 transgenic and nontransgenic
control mice was hybridized to a
hCD2 cDNA probe. Total RNA
(10mg) from thymuses of F5
transgenic and nontransgenic
control mice were hybridized to
probes specific for the Vc4 and
V]/11 gene segments.162 C. MAMALAKI et al.
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FIGURE 2. Expression of V]/11 on thymocytes and lymph node cells from F5 TcR transgenic and control nontransgenic mice.
Thymocytes from F5 transgenic or control nontransgenic mice were stained with FITC-conjugated anti-CD8, anti-CD4-RED613R,
and KT11 anti-V]/11 antibody, followed by phycoerythrin-conjugated streptavidin. V]/11 expression (A) on total thymocytes from
F5 TcR transgenic and nontransgenic mice; (B) on gated CD4-CD8-(DN), CD4/8/(DP), CD4/8 (CD4/), CD4-CD8 (CD8/) thymic
subpopulations.F5 T-CELL-RECEPTOR TRANSGENIC MICE 163
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FIGURE 2. Expression of V]/11 on thymocytes and lymph node cells from F5 TcR transgenic and control nontransgenic mice.
Thymocytes from F5 transgenic or control nontransgenic mice were stained with FITC-conjugated anti-CD8, anti-CD4-RED613R,
and KT11 anti-V/11 antibody, followed by phycoerythrin-conjugated streptavidin. V/11 expression; (C) on total lymph node
cells from F5 TcR transgenic an& nontransgenic control mice stained as before; and (D) on different subpopulations of lymph
node cells.164 C. MAMALAKI et al.
transgenic mice. One population with low levels
of TcRafl expression (TcR1) and a population
expressing the Vf111 TcR chain at levels that were
intermediate (TcRint) between this low (TcR1)
level of expression and the high (TcRhi) levels
found on mature single-positive thymocytes of
nontransgenic mice (Fig. 2A).
To follow the expression of the transgenic T-
cell receptor in different subpopulations of thym-
ocytes, we performed three-color fluorometric
analysis using antibodies recognizing CD4, CD8,
and Vf111 TcR molecules (Fig. 2B). The majority
of CD4/8
/ and 20-50% of CD4-8- thymocytes
express low levels of the Vf111 TcR chain. The
majority (>90%) of CD8/4 thymocytes express
the intermediate levels of Vf111 TcR chain,
whereas a smaller proportion (70-90%) of the
CD8-4
/ single-positive cells were Villi-positive.
In Figs. 2C and 2D, similar analysis of lymph
node cells from F5 transgenic mice showed that
over 95% of CD8/CD4 cells were expressing Vfl
11, whereas a significant proportion of CD4/CD8
cells (40-60%) were Vf111 negative. It is not clear
which Vfl gene segment these CD4/Vf111 cells
are expressing. There was a small population of
CD4/8 lymph node T cells expressing a high
level of Vf111. No significant expression of Vf111
was found in the CD4-8- cell population in the
lymph nodes (Fig. 2D).
Positive Selection in F5 Transgenic Mice
In order to study the effect of the F5 transgenic
receptor expression on the CD4//CD8
/ ratio, thy-
mocytes and lymph node cells from the F5 mice
were stained with anti-CD4 and anti-CD8 anti-
bodies. In F5 transgenic mice, the proportion of
CD8/4 thymocytes was significantly increased
when compared to nontransgenic littermates
from about 2% in nontransgenic mice to about
8-30% in F5 transgenic mice (Figs. 3 and 4C). A
concomitant decrease in the proportion of CD4/8
mature thymocytes was observed from about 9%
in nontransgenic to about 2% in F5 transgenic
mice (Fig. 3).
Similarly, a pronounced increase in the pro-
portion of CD8/4 cells was observed in the
lymph nodes of transgenic mice (Fig. 3). Thus,
approximately 70% of the. transgenic lymph node
cells were of CD8/4 phenotype, whereas in non-
transgenic lymph nodes, the proportion of
CD8/4 cells was 25%. This represents a change in
the ratio of CD8//CD4+ cells from 0.5 in non-
transgenic to 8 in the F5 transgenic lymph nodes.
We conclude from these results that in H-2
b
haplotype, positive selection of thymocytes
carrying the F5 T-cell receptor occurs and this
leads to skewing toward a CD8
/ phenotype
reflecting the phenotype of the original clone
from which the T-cell receptor was isolated.
These results are consistent with previous studies
in other TcR transgenic systems (Kisielow et al.,
1988b; Sha et al., 1988b; Kaye et al., 1989).
Effects of Expression of IE and Mtv Products in
the Development of Thymocytes and T cells in
F5 Transgenic Mice
The F5 T-cell receptor utilizes the Vf111 segment
of the fl-chain gene family. T cells carrying the
Vf111 chain are normally clonally deleted in mice
expressing a functional IE molecule and products
from Mtv 8, 9, or 11 integrants (Dyson et al.,
1991). In order to study the influence of these
proteins on the development of Villi-bearing
thymocytes, we bred the C57BL/10 F5 transgenic
mouse to CBA/Ca (H-2k; IE/; Mtv 8
/ and 9/) and
to BALB/c (H-2d; IE/; Mtv 6/, 8/, and 9/) mice. F1
(bxk or bxd) mice were backcrossed to CBA/Ca
or BALB/c, respectively, and bk, kk or bd, dd,
and F5
/ progeny were identified as described in
Materials and Methods and analyzed by three-
color fluorometric analysis using monoclonal
antibodies against CD4, CD8, and Vf111. Figure
4A shows that the proportion of CD8/4 thymo-
cytes was reduced from 20% in bb mice to 4% in
bk and 2% in kk F5 transgenic mice. The
decrease, which was also observed in bd and dd
mice (Fig. 4B), in which the proportion of CD8/4
thymocytes was reduced to approximately 2%, is
unlikely to be due to the absence of positive
selection as the heterozygote (bk or bd) mice had
just as few CD8/4 thymocytes as the dd and kk
animals, despite the presence of the H-2
b posi-
tively selecting allele. The percentage of CD4+8
/
double-positive thymocytes was increased
slightly, but the actual cell number was not sig-
nificantly affected.
In the periphery of bd and dd F5 transgenic
mice, analysis of lymph node cells showed a
reduction of CD8/4 cells from 70% to 28% and
24%, respectively (Fig. 4B), whereas in lymph
nodes of bk and kk mice, the reduction was less
pronounced (Fig. 4A). Figure 4C represents theF5 T-CELL-RECEPTOR TRANSGENIC MICE 165
proportions of CD4/8 or CD4-8
/ cells found in
the differentMHC haplotype mice.
Expression of VJll on Thymocytes and T Cells
in F5 Transgenic Mice Expressing IE and Mtv
Products
Thymocytes and peripheral T cells from F5 trans-
genic mice of bk, kk, bd, and dd haplotypes were
examined by three-color fluorometric analysis
using monoclonal antibodies against CD4, CD8,
and V]/11.
Figure 5 shows such an analysis comparing the
V]/11 levels on thymocytes from a bb F5 trans-
genic mouse to those found on thymocytes from
a bk F5 transgenic mouse. Thymocytes from the
bk mice had lost the intermediate level of Vf111
expression and most thymocytes were expressing
low levels. The level of V]/11 expression on the
CD4+8
/ was unaffected, whereas most of the
single-positive CD4/8 or CD4-8
/ populations
express no or low levels of V]/11, with the CD4/8
population being most affected.
In the peripheral lymphoid tissues of F5 trans-
genic mice expressing IE and Mtv products,
mature T cells that had low or very low levels of
Vf111 on their surface predominated (Fig. 5A).
However, in F5 transgenic mice of H-2
bk or H-2
kk
haplotype, a proportion of CD8
/ cells persists
that have V]/11
int levels similar to those observed
in the bb F5 TcR transgenic mice. No expression
of Vf111 was observed in the double-negative
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FIGURE 3. Positive selection in F5
transgenic mice. Thymocytes and
lymph node cells of F5 and non-
transgenic mice were stained with
anti-CD4 and anti-CD8 antibodies
and the proportion of the different
subpopulations was determined.166 C. MAMALAKI et al.
CD4-8-population in the lymph node cells of
these mice (Fig. 5B).
We conclude from these results that expression
of IE molecules in association with endogenous
Mtv products leads to clonal deletion of V//11-
bearing, Mtv-reactive cells at the late double-
positive stage. Most of the cells that escape to the
periphery appear to have downregulated their
expression of Vf111 or had low levels of Vf111
originally.
Functional Properties of T Cells from F5
Transgenic Mice
In order to assess the ability of the T cells from
the F5 transgenic mice to recognize the cognate
peptide on appropriate target cells, cytotoxic
assays were performed, as described in Materials
and Methods. From Table 1, it can be seen that
the presence of IL-2 in the culture medium is
required for the generation of peptide-specific
cytotoxic T cells from F5 transgenic mice. Spleen
cells taken directly from mice were not cytotoxic
(data not shown and Mamalaki et al., 1992)
unless mice had been injected with peptide in
vivo (Mamalaki et al., 1992). Cultures generating
peptide-specific cytotoxic T cells showed devel-
opment of blast cells from day 2 or 3 after cul-
ture: Assays for cytotoxicity were generally per-
formed on day 5, but cytotoxicity could be seen
from day 4 to day 7.
Cultures stimulated with peptide-pulsed B10
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FIGURE 4. Deletion of mature transgenic lymphocytes in the presence of IE and endogenous superantigens. (A) Thymocytes
bb bk kk and lymph node cells from transgenic animals of H-2 H-2 and H-2 haplotypes were stained as described in Fig. 2 and the
patterns of expression of CD4 and CD8 are shown.F5 T-CELL-RECEPTOR. TRANSGENIC MICE 167
splenic cells (B10p) in the absence of IL-2 showed
no evidence of proliferation or differentiation
into cytotoxic effector cells. Percentage recovery
of cells (a measure of proliferation) from cultures
containing IL-2 but no peptide-pulsed B10
splenic cells (B10p) was lower than those with
both IL-2 and B10p, but levels of cytotoxicity were
comparable, or only slightly lower (Table 2). Per-
centage recoveries of cells from cultures with IL-
2 and B10p were always higher than those with
B10 spleen cells not pulsed with peptide (B10)
(Table 1).
Despite the thymic deletion or failure to posi-
tively select CD8 Vf111
+ T cells in bk or kk mice
(see Fig. 4), their peripheral T cells could gener-
ate peptide-specific cytotoxic T cells after in vitro
culture in the presence of IL-2 (Table 2). In the
case of spleen cells from kk mice, the inclusion of
B10p in the culture did not increase percentage
recoveries and tended to increase the level of
nonspecific alloreactive lysis of EL-4 cells (Table
2).
T Cells Bearing the Transgenic T-Cell Receptor
Accumulate in F5 Scid Transgenic Mice
The presence of T cells that can kill targets in an
antigen-dependent.manner in the periphery of F5
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FIGURE 4. Deletion of mature transgenic lymphocytes in thed presence of IE and endogenous superantigens. (B) Thymocytes
bb dd and lymph node cells from transgenic animals of H-2 H-2 and H-2 haplotypes were stained as described in Fig. 2 and the
patterns of expression of CD4 and CD8 are shown.168 C. MAMALAKI et al.
transgenic mice of MHC bk, kk, bd, and dd
haplotype indicated that these T cells may have
been positively selected in the thymus using
endogenously rearranged c chains that then pair
with the transgenic V]/11. Such cells could carry
heterodimers of F5 otg/Jtg type and random oend/J
tg
type. It is possible that such cells would be selec-
ted on the oend#
g pair, but could kill targets in an
antigen-dependent manner using the otg/Jtg. TO
test this possibility, F5 transgenic mice were
backcrossed to BALB/c scid/scid mice. F5 mice
homozygous for the scid mutation (scid/scid)
and homozygous or heterozygous for H-2 (dd,
db) were compared with F5 mice of scid/+ or
+/+ and of dd or bd H-2 haplotype. Three-color
fluorometric analysis showed similar subpopu-
lation distribution to that shown in Fig. 4B, indi-
cating no additional effect on the transgene
phenotype of the scid mutation.
Table 3 shows the results of culturing spleen
cells from F5 transgenic mice crossed and then
backcrossed onto BALB/c scid/scid mice. There
was no difference in the ability of bd and dd F5
mice, either heterozygous or homozygous for the
scid mutation, to generate peptide-specific cyto-
toxic T cells in culture.
These results appear to exclude the possibility
that the T cells found in the periphery of bd, dd,
bk, and kk mice have necessarily been positively
selected using T-cell receptors that utilize
endogenously rearranged o- and ]/-chain genes,
unless in the used scid/scid mice, the defect in
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FIGURE 4. Deletion of mature transgenic lymphocytes in the presence of IE and endogenous superantigens. (C) Variability in
proportion of CD4/8 and CD4-8 cells in thymus and lymph node of F5 transgenic mice of differentMHC haplotypes.F5 T-CELL-RECEPTOR TRANSGENIC MICE 169
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FIGURE 5. Downregulation of
V]/ll expression in the presence of
IE and endogenous superantigens.
(A) Expression of V11 on total thy-
mocytes and lymph node cells from
F5 TcR transgenic mice of H-2b/b
b/k (solid lines) or H-2 (dashed lines)
haplotype. (B) Expression of V]/11
on the different subpopulations in
thymocytes and lymph node cells
from mice as described in Fig. 5A
and stained as described in Fig. 2.
the rearrangement of the TcR loci is not
complete.
DISCUSSION
We have generated a mouse transgenic for a T-
cell receptor (F5) speeific for a peptide
(cc366-374) of nucleoprotein of influenza virus
in association with Class I MHC Db. These mice
show accumulation of single-positive CD8
/ lym-
phocytes in the thymus and in the periphery as a
result of positive selection. Analysis of receptor
expression using a monoclonal antibody that
recognizes the V]/11 chain of the F5 receptor
showed that almost all CD8
/ cells (>90%) express
the transgenic V]/ chain, whereas within the
CD4
/ population only 70-90% of the cells express
the transgenic V]/11 in the thymus and 40-60% in
the lymph nodes. It is possible that CD4
/ cells in
the F5 transgenic mice are selected using
endogenous o chains that can form functional
dimers with the transgenic V/J11 or other170 C. MAMALAKI et al.
TABLE
Conditions for Generation of Peptide-Specific Cytotoxic T Cells from F5 Transgenic Mice
Experiment Culture conditions
No. responding cells IL-2 B10 B10 % recovery EL-4
% lysis
EL-4
1x106 + 100 0 0
1x106 + + 225 2 62
5x106 + 90 0 0
5x106 + + 330 3 66
1106 + 95 0 0
1x106 + 95 0 22
1x106 + + 95 0 29
lx106 + + 330 0 42
3 2x106 + + 50 19 54
2x106 + + 93 5 57
TABLE 2
Function of F5 Transgenic Responder Spleen Cells from F5 bb,
bk, and kk Mice
Experiment Responder Culture conditions % lysis
IL-2 B10 o recovery EL-4 EL-4
bb + + 400 19 54
+ 93 20 39
bk + + 240 22 54
+ 120 20 38
kk + + 140 33 55
+ 120 16 36
bb + + 120 8 52
+ 110 9 35
bk + + 140 11 46
+ 90 14 46
kk + 120 20 46
+ 130 9 39
endogenous V]/ chains, which have escaped
allelic exclusion, thus generating Class II MHC
restricted T cells that are subsequently positively
selected.
Spleen cells from the F5 transgenic mice can be
stimulated in vitro to differentiate into effector
cells that kill target cells in an antigen-dependent
manner. This differentiation is dependent on the
presence of IL-2 in the culture medium during a
4-5 day culture period. F5 T cells do not replicate
or die in culture in the absence of IL-2 (Table 1)
and do not become effector cells in the protocol
described in this paper. It is unclear at the
moment whether the peripheral T cells in F5
C57BL/10 mice are in an’anergic state and, if so,
why.
The F5 T-cell receptor utilizes the V]11 mem-
ber of the TcR]/gene family. Most cells carrying
TABLE 3
Peptide-Specific CTL from Spleens of scid/+ and scid/scid F5
Transgenic Mice
Responder Culture conditions % lysis
H-2 scid IL-2 % recovery EL-4 EL-4
bd scid/+ + 112 13 52
dd scid/+ + 45 13 62
bd scid/scid + 62 12 69
dd scid/scid + 50 5 60
the V]/11 chain are clonally deleted in mice that
express a functional Class II MHC IE o//hetero-
dimer and certain endogenous Mtv genes. In
order to study the effects of such deleting
elements on the development and function of F5
transgenic lymphocytes, we bred the transgenic
F5 (C57BL/10 H-2b) mice to CBA/Ca H-2
k or
BALB/c H-2
d backgrounds. F1 mice and their
backcrosses to CBA/Ca and BALB/c F2 mice
were analyzed for T-cell development and their
ability to kill target cells in a peptide-dependent
manner. Phenotypic analysis showed that the
number of mature single-positive CD8
/ cells car-
rying the V]/11 TcR chain are reduced in kb, kk,
db, and dd mice. We conclude from this that
most of the mature Villi-bearing lymphocytes
are clonally deleted in these mice in an effort to
establish tolerance to endogenous superantigens.
As in normal H-2 IE
/ mice with Mtv 8, 9, or 11
genomes (Dyson et al., 1991), a small percentage
of V]/11 cells escape deletion and appear in the
periphery. The remaining V]/11
/ CD8
/ or Vf111
+
CD4
/ cells found in the thymus and the periph-
ery have reduced levels of transgenic TcR.
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as evidenced by the absence of single-positive
cells and possibly downregulation of the T-cell
receptor levels are used to establish and maintain
functional tolerance.
This differs from the findings in adult F5 trans-
genic mice injected intraperitoneally with the
cognate peptide. Under these conditions, it is the
double-positive cells that are depleted in the thy-
mus. This difference could be explained by levels
of presented antigen: Mtv products are in lower
abundance than the levels of administered pep-
tide. Such a hypothesis would predict that suffic-
iently low levels of administered peptide would
eventually deplete the thymus from single-posi-
tive cells leaving the double-positive population
intact. However, in titration experiments of pep-
tide dose, we failed to observe this phenomenon.
Instead, the extent of depletion of the double-
positive population was dependent on peptide
concentration, with no effect seen using
0.25 nmol/g weight. Alternatively, peptide injec-
tion leads to presentation of the antigen by all
cells expressing MHC, whereas Mtv products
may be synthesized in a subpopulation of
antigen-presenting cells. The mechanisms under-
lying this difference are under investigation in
our laboratory at the moment. These results are
reminiscent of the findings by Pircher and col-
leagues. In that model, mice transgenic for a TcR
specific for lymphocytic choriomeningitis virus
(LCMV) and mixed lymphocyte stimulatory
(Mls) antigen were examined for tolerance to
these two antigens. Thus, mice tolerant to LCMV
have low numbers of CD4/8+ thymocytes,
whereas mice tolerant to Mls show deletion of
single-positive mature cells (Pircher et al., 1989).
Functional studies on spleen cells from bk, kk,
bd, or dd mice showed that such circulating lym-
phocytes can be stimulated to kill target cells in
an antigen-dependent manner. Thus, the mature
T cells found in these mice carry a potentially
functional receptor, but are probably kept in an
anergic or quiescent state within the mouse until
they are cultured in vitro in the presence of IL-2.
There have been a number of examples of
potentially self-reactive T cells that fail to be acti-
vated in vivo but can be activated in vitro in the
presence of IL-2 (Essery et al., 1988; Beverly et al.,
1992). A similar mechanisfn may operate in the
case of the bk, kk, bd, and dd F5
/ mice in which
IL-2 addition to cultures may cause a reversal of
the in vivo anergic state of these lymphocytes.
Experiments addressing the ability for response
to antigen in vivo in these mice are currently
under way.
The circulating T cells in these mice bearing a
potentially functional transgenic receptor might
arise by positive selection of T cells that have
rearranged endogenous C-chain genes that can
form positively selectable T-cell receptors in
association with the transgenic Vf111. Spleen cells
from these mice would contain T cells that bear
two chains and that would be capable of killing
target cells in an antigen-dependent manner, if
properly stimulated. In order to investigate this
possibility, we backcrossed the F5 TcR transgenic
mice to scid/scid BALB/c mice until we obtained
scid/scid, F5/, H-2
bd or scid/scid, F5/, H-2
dd mice.
Because the scid/scid genotype ensures
impaired, if not entirely abolished, ability to
rearrrange productively the TcR and ]/loci, T
cells appearing in these mice would carry obli-
gatorily the transgenic ]/dimer. Indeed, the thy-
mus develops normally in scid/scid, F5/, H-2
dd
mice with the expected clonal deletion of most of
the mature single-positive populations because
of endogenous Mtv-derived superantigens of
BALB/c and C57BL/10 background. To our sur-
prise, in the periphery of these mice, T cells of
CD4
/ or CD8
/ phenotype carrying the transgenic
receptor are present, albeit in lower numbers.
Therefore, the presence of endogenous c chains
that rescue these cells in an IE
/ Mtv
/ background
seems unlikely, but cannot be excluded at the
moment, because productive rearrangements can
occur to a certain degree even in scid/scid mice.
The mature T cells in these mice appear to be cap-
able of differentiating in the presence of IL-2 to
kill target cells in an antigen-dependent manner.
We are left with only a few explanations for this
phenomenon. One would entail the presence of a
cross-reacting, positively selecting element in
BALB/c background that allows the maturation
of some cells. The fact that we obtained similar
results using two different H-2 haplotypes
argues against such an explanation, but cannot
be excluded at present. Alternatively, clonal
deletion of the reactive V]/11
+ T cells by the k or d
haplotypes is inefficient due to the sheer num-
bers of thymocytes bearing this receptor. Those
that escape in the periphery appear to be unreac-
tive to endogenous IE and Mtv products due to
downregulation of the transgenic T-cell receptor
levels. These cells, however, can be triggered in172 C. MAMALAKI et al.
vitro by appropriate lymphokines. Finally, it is
not entirely unlikely that the cells do not need to
pass through a positive selection stage if they
carry a rearranged functional T-cell-receptor
gene complement. Such receptor would have
been positively selected for its usefulness during
its original appearance in the influenza immun-
ized mouse from which the F5 cytotoxic T-cell
clone was isolated. In the F5 TcR transgenic
mouse, this would imply that positive selection is
not a change in the metabolism or state of the
developing thymocyte, simply that positive
selection is the result of a TcR engagement in a
way that does not lead to deletion.
MATERIALS AND METHODS
Gene Construct and Transgenic Mice
The cDNAS for the o and ]/chains of the F5 T-cell
receptor were cloned in the 5’ untranslated
region of the human CD2 mini gene (Greaves et
al., 1989). A human CD2 minigene that carries a
frameshift mutation in its coding region was par-
tially digested with SacI. The linearized fragment
at the SacI site in the first exon was isolated,
treated with $1 nuclease, and the ends were
blunted using the Klenow fragment of DNA
polymerase I. A unique synthetic EcoRI site was
cloned into the blunted SacI site. The artificial
EcoRI was blunt-ended and the cDNAs for the o
and ] chains of the F5 T-cell receptor (Palmer et
al., 1989) were inserted in this position.
The chimeric F5o and F5]/ constructs were
coinjected into C57BL/10 embryos as previously
described (Lang et al., 1988). The transgenic ani-
mals were crossed with either C57BL/10,
CBA/Ca, BALB/c, or scid/scid mice. H-2bk, H-
2kk, H-2bd, or H-2
dd haplotypes of F5 transgenic
mice were determined by Southern blot analysis
using a 0.68-kb BamHI fragment 5’ to the H-2Kb
gene (Weiss et al., 1984). F5 transgenic mice were
typed scid/scid by quantitating serum immuno-
globulin levels. Preparation of DNA and RNA
and analysis by Southern or Northern blot were
carried out as described (Lang et al., 1988).
Flow Cytometry
For three-color analysis, 10 thymocytes or lymph
node cells were stained with FITC-conjugated
anti-CD8 (53-6.7), (Becton & Dickinson), anti-
CD4-RED613 (YTS 191.1.2) (Gibco BRL), and biot-
inylated KTII anti-V11 antibody (kind gift from
Kyuhei Tomonari, CRC) (Tomonari and Lover-
ing, 1988), followed by phycoerythrin-conjugated
streptavidin (Biogenesis).
In vitro Cultures
Spleens were removed aseptically from F5 trans-
genic mice, their nontransgenic littermates, and
nontransgenic C57BL/10 mice. The ages of mice
used ranged from 3 to 8 weeks. Spleens were
teased into cell suspensions in balanced salt
solution (BSS) containing 2% fetal calf serum
(FCS), filtered through nylon mesh to remove cell
clumps, and then centrifuged. Pellets of spleen
cells to be used as a source of antigen were then
treated to remove red blood cells, using brief
exposure to distilled water followed by resto-
ration to isotonicity with 10xBSS and then centri-
fuged. Cell pellets were resuspended in complete
RPMI medium (RPMI 1640 with 10% FCS, 10mM
Hepes of pH 7.2, 5x10-SM 2-mercaptoethanol,
glutamine, penicillin, and streptomycin) and
counted. An appropriate number of cells to be
used as antigen were sensitized with influenza
nucleoprotein peptide (NP 366-379) by adding
10 tl of peptide at 100 tM per 107 cells to the cell
pellet. They were then incubated at 37C for
45 min, washed twice in complete RPMI medium,
resuspended at an appropriate concentration,
and irradiated before addition to cultures. Spleen
cells to be used as responders did not have red
blood cells removed, but were suspended in com-
plete RPMI medium, counted, and adjusted to an
appropriate concentration for culture.
Cytotoxic T-cell Assays
These were carried out using as targets EL-4 cells
growing in log phase in vitro: 2106 EL-4 were
labeled for 60 min at 37C in 0.1 ml BSS medium
containing 100/Ci 51Cr sodium chromate: To a
pellet of another aliquot of 2106 EL-4 was added
100/1 of 100 tM influenza nucleoprotein peptide
NP 366-379 together with 100 tCi 51Cr sodium
chromate and incubation carried out for 60 min
at 37C. After incubation, both aliquots of EL-4
were washed twice and then resuspended in
complete RPMI medium at 1x105/ml before dis-
pensing 100/1 (1x104) into each microtitre well toF5 T-CELL-RECEPTOR TRANSGENIC MICE 173
which effector T cells had been added. Effector
cells were harvested from spleen cells of trans-
genic mice and cultured at 37C in a 5% CO2
atmosphere for 5 days in the presence of
50 IU/ml rIL-2 with or without C57BL/10 spleen
cells sensitized or not with NP 366-379 peptide,
as described before. Effector cells were har-
vested, centrifuged, and resuspended in fresh
complete RPMI medium, counted, and then vol-
ume adjusted to give a concentration of 3x
106/ml. Each effector cell suspension was dis-
pensed in round-bottomed microtitre wells in a
volume of 100/1 in triplicate and then four serial,
one in three dilutions, were carried out. After
addition of lx104 target cells/well, effector-to-
target-cell ratios of 30:1, 3:1, and 1:1 were pre-
sent. The assay plates were briefly centrifuged
and then incubated for 3 hr at 37C in a 5% CO2
atmosphere. 100/1 of supernatant was then har-
vested from each plate and counted for 51Cr. The
percent specific lysis was calculated according to
the formula:
% specific lysis=(E-C/M-C)xlO0
where E is the cpm from wells with effectors pre-
sent, C is the cpm from control wells with target
cells incubated in medium alone, and M is the
maximum released counts from target cells incu-
bated with 5% Triton-100. Twelve-point
regression analysis was performed for each
titration curve and the % lysis at an effector:tar-
get ratio of 10:1 was taken from this curve. Sig-
nificant positive lysis was taken as levels over
10% specific lysis from curves where the r value
lay between 0.80 and 1.00. These are underlined
in the tables.
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